Blueprint Medicines

MA BD deal handshake cooperation collaboration business deal
Pharma

2025's top biopharma M&A deals

Looming patent expirations and a thawing of the biotech investment scene prompted drug developers of all stripes to pull out their checkbooks in 2025.
Sanofi

Sanofi buys Blueprint for $9.1B, its largest deal in 7 years

Jun 2, 2025 11:09am
Blueprint Medicines Colors of SM art show

Blueprint art show illustrates life with systemic mastocytosis

Jul 31, 2024 3:10pm
Borisy

Alexis Borisy sheds 2 board jobs to stay with Blueprint

Apr 30, 2024 7:20am
relay

After Roche breakup, Blueprint finds Gavreto a new home at Rigel

Feb 22, 2024 10:33am
Ayvakit

Blueprint boosts Ayvakit peak sales estimate to $2B

Feb 15, 2024 7:00am